Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Swiss Hernia Days 2025

The 8th Swiss Hernia Days conference is scheduled to be held from October 23-24, 2025, in Basel, Switzerland. Building on six successful years, the organizers [...]

Go to Top